First Line Treatment in stage || Hypertension with High CV Risk
Biotelm-CH80
Telmisartan 40mg+Chlorthaildone12.5mg Tablets
- Reduce risk of HF by 49% and risk of MI by 33%.
- More effective in preventing CHF and CHD
- Only ARB indicated to reduce CV morbidity and mortality i high risk patients.
- CTD has more favourable pleiotropic effects relating to platelet aggregation and angiogenesis.





